Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
July 19 2024 - 6:22AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-163
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of July 2024
Alterity
Therapeutics Limited
(Name
of Registrant)
Level 14, 350 Collins Street,
Melbourne, Victoria 3000 Australia
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980
and 333-228671) and our
Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417
and 333-250076)
ALTERITY
THERAPEUTICS LIMITED
(a
development stage enterprise)
The
following exhibits are submitted:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Alterity Therapeutics Limited |
|
|
|
|
By: |
/s/ Geoffrey P. Kempler |
|
|
Geoffrey P. Kempler |
|
|
Chairman |
Date:
July 19, 2024
2
Exhibit 99.1
![](https://www.sec.gov/Archives/edgar/data/1131343/000121390024062728/ex99-1_001.jpg) |
Appendix 2A - Application for quotation of securities
|
Announcement
Summary
Entity name
ALTERITY THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Friday July 19, 2024
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX +security code | |
+Security description | |
Number of
+securities to
be quoted | | |
Issue date | |
| |
| |
| | |
| |
ATH | |
ORDINARY FULLY PAID | |
| 75,220,800 | | |
| 18/07/2024 | |
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities | 1 / 6 |
![](https://www.sec.gov/Archives/edgar/data/1131343/000121390024062728/ex99-1_001.jpg) |
Appendix 2A - Application for quotation of securities
|
Part 1 - Entity and announcement details
1.1
Name of entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the
following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
|
1.2 Registered number type | Registration number |
|
|
|
|
ABN |
37080699065 |
1.3
ASX issuer code
ATH
1.4
The announcement is
New announcement
1.5
Date of this announcement
19/7/2024
Appendix 2A - Application for quotation of securities | 2 / 6 |
![](https://www.sec.gov/Archives/edgar/data/1131343/000121390024062728/ex99-1_001.jpg) |
Appendix 2A - Application for quotation of securities
|
Part 2 - Type of Issue
2.1
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
|
Announcement Date and Time |
Announcement Title |
Selected Appendix 3B to submit quotation request |
|
|
|
|
|
18-Jul-2024 12:16 |
New - Proposed issue of securities - ATH |
A placement or other type of issue |
2.3a.2 Are there any further issues of +securities
yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No
Appendix 2A - Application for quotation of securities | 3 / 6 |
![](https://www.sec.gov/Archives/edgar/data/1131343/000121390024062728/ex99-1_001.jpg) |
Appendix 2A - Application for quotation of securities
|
Part 3A - number and type of
+securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
Placement Details
ASX +security
code and description
ATH : ORDINARY FULLY PAID
Issue date
18/7/2024
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities
held by the recipients in each category.
|
Number of +securities held |
|
Number of holders |
|
Total percentage of +securities held
For example, to enter a value of 50% please input as 50.00 |
|
1 - 1,000 |
|
|
|
% |
|
1,001 - 5,000 |
|
|
|
% |
|
5,001 - 10,000 |
|
|
|
% |
|
10,001 - 100,000 |
|
|
|
% |
|
100,001 and over |
|
|
|
% |
Appendix 2A - Application for quotation of securities | 4 / 6 |
![](https://www.sec.gov/Archives/edgar/data/1131343/000121390024062728/ex99-1_001.jpg) |
Appendix 2A - Application for quotation of securities
|
Issue details
Number of +securities to be quoted
75,220,800
Are the +securities being issued for a cash consideration?
Yes
|
In what currency is the cash consideration being paid? | | What
is the issue price per +security? |
|
| | |
|
AUD - Australian Dollar | | AUD 0.00540000 |
Any other information the entity wishes to provide about the +securities to be quoted
Appendix 2A - Application for quotation of securities | 5 / 6 |
![](https://www.sec.gov/Archives/edgar/data/1131343/000121390024062728/ex99-1_001.jpg) |
Appendix 2A - Application for quotation of securities
|
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject
of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically
generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently
with ASX for processing.
4.1
Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the
+securities subject of this application)
ASX +security code and description |
|
Total
number of +securities
on issue |
|
ATH : ORDINARY FULLY PAID |
|
|
5,320,336,118 |
|
|
|
|
|
|
ATHO : OPTION EXPIRING 31-AUG-2026 |
|
|
932,706,668 |
|
4.2
Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description | |
Total
number of +securities
on issue | |
ATHAAI : OPTION EXPIRING 31-AUG-2024 EX $0.007 | |
| 1,935,759,704 | |
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | |
| 14,250,000 | |
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 | |
| 12,000,000 | |
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | |
| 11,900,000 | |
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | |
| 35,000,000 | |
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 | |
| 8,000,000 | |
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 | |
| 62,500,000 | |
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 | |
| 26,500,000 | |
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 | |
| 120,000,000 | |
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | |
| 91,392,720 | |
Appendix 2A - Application for quotation of securities | 6 / 6 |
Alterity Therapeutics (PK) (USOTC:PRNAF)
Historical Stock Chart
From Jul 2024 to Aug 2024
Alterity Therapeutics (PK) (USOTC:PRNAF)
Historical Stock Chart
From Aug 2023 to Aug 2024